Abstract Details
|
Josephe Archie Honorat, MD, PhD
PRESENTER |
Dr. Honorat has nothing to disclose. |
| Lars Komorowski | Lars Komorowski has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for EUROIMMUN . Lars Komorowski has stock in Revvity. Lars Komorowski has received intellectual property interests from a discovery or technology relating to health care. |
| Erik K. St. Louis, MD (Mayo Clinic) | The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Shannon Hinson | Shannon Hinson has received intellectual property interests from a discovery or technology relating to health care. Shannon Hinson has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| Neeraj Kumar, MD (Mayo Clinic, Dept of Neurology) | Dr. Kumar has nothing to disclose. |
| Vanda Lennon, MD, PhD (Mayo Clinic) | The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care. |
| Sean J. Pittock, MD, FAAN (Mayo Clinic Dept of Neurology) | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Andrew McKeon, MD (Mayo Clinic) | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |